House and Senate Appropriators Pledge to Increase Biomedical Research Funding.
Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center
Clinical Trials: NIH Health Plans Association, Agree In Principle to Raise Clinical Trial Enrollment
Cancer Screenings: American Over 50 Urged to Get Colon Caner Tests
Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High
Funding Opportunities: NCI Offers Grant Supplements
Foon To Direct Barrett Center; Hundahl Leads Commission
National Comprehensive Center Network, Quintiles Oncology, To Collaborate On Trials
Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System
Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says
Approvals and Applications: European Committee Signs Off On Paxene for KS reatment
Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms
Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol
Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ
